NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.

Published

Journal Article

The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma.

Full Text

Duke Authors

Cited Authors

  • Benson, AB; D'Angelica, MI; Abbott, DE; Abrams, TA; Alberts, SR; Saenz, DA; Are, C; Brown, DB; Chang, DT; Covey, AM; Hawkins, W; Iyer, R; Jacob, R; Karachristos, A; Kelley, RK; Kim, R; Palta, M; Park, JO; Sahai, V; Schefter, T; Schmidt, C; Sicklick, JK; Singh, G; Sohal, D; Stein, S; Tian, GG; Vauthey, J-N; Venook, AP; Zhu, AX; Hoffmann, KG; Darlow, S

Published Date

  • May 2017

Published In

Volume / Issue

  • 15 / 5

Start / End Page

  • 563 - 573

PubMed ID

  • 28476736

Pubmed Central ID

  • 28476736

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Language

  • eng

Conference Location

  • United States